Selective USP7 Inhibition Synergizes with MEK1/2 Inhibitor to Enhance Immune Responses and Potentiate Anti–PD-1 Therapy in NRAS-Mutant MelanomaLiya Su, Weijia Cai|Journal of Investigative Dermatology|2025Cited by 9